Mylan offers one of the broadest portfolios of active pharmaceutical ingredients (API)—the ingredients responsible for the therapeutic effects of different medicines—to more than 80 countries.
Quality begins at step one. Mylan uses an established testing and verification process to ensure the suitability of active ingredients used in our medicines.
Direct access to API makes Mylan one of only two global generics companies with a comprehensive, vertically integrated supply chain and helps us maintain deep insight into diverse markets and therapeutic segments.
Additionally, we’re one of the world’s largest producers of API for generic antiretrovirals (ARVs) for the treatment of HIV/AIDS, as well as antibacterials, central nervous system agents, antihistamines/anti-asthmatics, cardiovasculars, antivirals, antidiabetics, antifungals, proton pump inhibitors and pain management medicines.
With a commitment to quality, state-of-the-art API manufacturing facilities, global regulatory accreditations, a strong pipeline and speed-to-market capabilities, Mylan is an ideal API partner.